SlideShare ist ein Scribd-Unternehmen logo
1 von 72
Case-Control & Other Study Designs
Dr. Win Aye Hlaing
Lecturer
Department of Epidemiology
University of Public Health, Yangon
6/26/2017 1
• In the early 1940s, Alton Ochsner, a surgeon
• observed that patients with lung cancer gave a
history of cigarette smoking
• relationship is accepted and well recognized
today
• it was relatively new and controversial at the
time
• He hypothesized that cigarette smoking was
linked to lung cancer
6/26/2017 2
• In 1940s, Sir Norman Gregg, an Australian
ophthalmologist
• observed a number of infants and young children
who presented with an unusual form of cataract
• noted that these children had been in utero
during the time of a rubella (German measles)
outbreak
• Association between prenatal rubella exposure
and development of the unusual cataracts
• at that time there was no knowledge that a virus
could be teratogenic
• he proposed his hypothesis solely on the basis of
observational data
6/26/2017 3
• 90% of these infants had been in utero during the rubella
outbreak
• concluding that rubella was associated with the cataracts?
• Clearly, the answer is no
• difficult to interpret without data for a comparison group of
children without cataracts
• Study both mothers of children with the cataracts and
without cataracts
• They had been pregnant during the outbreak of rubella
• exposure history-no different for mothers of children with
cataracts than for mothers of controls
• the prevalence of rubella exposure was greater in children
with cataracts than in a group of children without cataracts
6/26/2017 4
• To determine the significance of such
observations
• a comparison or control group is needed
• Without such a comparison, only constitute a
case series
6/26/2017 5
6/26/2017 6
DESIGN OF A CASE-CONTROL STUDY
• A group of people with that disease (cases)
• A group of people without that disease(controls)
• Cases were exposed and were not
• Controls were exposed and were not
• case-control study---if there is an association of
an exposure with a disease,
• the prevalence of history of exposure---higher in
persons who have the disease (cases) than in
those who do not have the disease (controls)
6/26/2017 7
6/26/2017 8
Case
[Disease (+)]
Control
[Disease (-)]
Exposure (+) a b
Exposure (-) c d
a+c b+d
a/a+c b/b+d
• by selecting cases (with the disease) and
controls (without the disease)
• and then measure past exposure by interview
and by review of medical or employee records
or of results of chemical or biologic assays of
blood, urine, or tissues
6/26/2017 9
• If exposure is associated with disease,
a/a + c ˃ b/b + d
• proportion of the cases who were exposed is
greater than proportion of the controls who
were exposed
6/26/2017 10
6/26/2017 11
• data from a case-control study,
• We cannot estimate the prevalence of the
disease
• E.g. we had 200 cases and 400 controls, but
this does not imply that the prevalence is 33%
or 200/200 + 400
6/26/2017 12
• the investigator could have selected
• 200 cases and 200 controls (1 control per case),
or
• 200 cases and 800 controls (4 controls per case)
• Because the proportion of the entire study
population that consists of cases is determined by
the ratio of controls per case, and this proportion
is determined by the investigator, it clearly does
not reflect the true prevalence
6/26/2017 13
• erroneous impression that
– cohort studies go forward in time and
– case-control studies go backward in time
• Such a distinction is not correct
• retrospective has been used for case-control
studies
• But retrospective cohort study also uses data
obtained in the past
• Thus, calendar time is not the characteristic that
distinguishes a case-control from a cohort study
6/26/2017 14
• Why the unusual number of controls?
• The investigation planned for two controls per
case (400 controls), and that some of the
controls did not participate
6/26/2017 15
Potential Biases in Case-Control Studies
• Selection Bias
– Selection of case
– Selection of control
• Information Bias
– Limitations in recall
– Recall bias
6/26/2017 16
Selection Bias – Selection of Case
• cases can be selected from a variety of sources,
including hospital patients, patients in physicians’
practices, or clinic patients
• Several problems---selected from a single hospital
• results may not be generalizable to all patients
with the disease
• cases are drawn from a tertiary care facility,
which selectively admits severely ill patients---
risk factors only in persons with severe forms of
the disease
6/26/2017 17
Using Incident or Prevalent Cases
• if we use prevalent cases(already been
diagnosed) :
– a larger number of cases is often available for
study and
– Most people with disease die soon after diagnosis
– Underrepresented in a study
– Highly non-representative group of cases
6/26/2017 18
• If we use incident cases:
– The problem is - wait for new cases to be
diagnosed
– But can exclude that any patients who may have
died before the diagnosis was made
6/26/2017 19
Selection of Controls
• In 1929, Johns Hopkins University
• test the hypothesis that tuberculosis
protected against cancer
• From total 7,500 consecutive autopsies
• Selected 816 cases of cancer and control
group of 816
6/26/2017 20
6/26/2017 21
Case
[Cancer (+)]
Control
[Cancer(-)]
TB (+) 54 133
TB (-) 762 683
816 816
6.6% 16.3%
• Of the 816 autopsies of patients with cancer
• 54 had tuberculosis (6.6%)
• whereas of the 816 controls with no cancer
• 133 had tuberculosis (16.3%)
• the prevalence of tuberculosis was higher in
the control group than in the case group
• concluded that tuberculosis had an
antagonistic or protective effect against
cancer
6/26/2017 22
• At the time of the study, tuberculosis was one of
the major reasons for hospitalization at Johns
Hopkins Hospital
• Inadvertently done in choosing the cancer-free
control group was diagnosed with and
hospitalized for tuberculosis
• selected the controls, they came from a pool that
was heavily weighted with tuberculosis patients,
which did not represent the general population
• Clearly, this conclusion was not justified on the
basis of these data
6/26/2017 23
• A fundamental conceptual issue relating to
selection of controls is:
• the controls should be similar to the cases in
all respects other than having the disease or
• they should be representative of all persons
without the disease in the population from
which the cases are selected
6/26/2017 24
• Controls may be selected
• from non-hospitalized persons living in the
community or
• from hospitalized patients admitted for
diseases other than that for which the cases
were admitted
6/26/2017 25
6/26/2017 26
Use of Hospitalized Patients as Controls
• more economical
• ill-defined reference population that generally
cannot be characterized
• a conceptual attractiveness to comparing
hospitalized cases to hospitalized controls
from the same institution who come from the
same reference population
6/26/2017 27
Use of Non-Hospitalized People as Controls
• Other sources include school rosters, selective service
lists, and insurance company lists
• neighborhood in which the case lives--- neighborhood
controls
• identify the home of a case as a starting point
• and from there walk past a specified number of houses
in a specified direction and seek the first household
that contains an eligible control
• Because of increasing problems of security in US, many
people will no longer open their doors to interviewers
• in developing countries, the door-to door approach to
obtaining controls may be ideal
6/26/2017 28
• Alternate method for selecting such controls is
to use random digit dialing
• a case’s seven-digit telephone number,
• the first three digits are the constant,
• the terminal four digits of the phone number
are randomly selected
6/26/2017 29
• Another approach to control selection is to use a best
friend control
• A case is asked for the name of a best friend who
participate in the study
• there are also disadvantages:
• A control is similar to the case in age and in many other
demographic and social characteristics
• A resulting problem may be that the controls may be
too similar to the cases in regard to many variables,
including the variables that are being investigated in
the study
• it may be useful to select a spouse or sibling control
• a sibling may provide some control over genetic things
6/26/2017 30
Information Bias – Limitations in Recall
• collecting data from subjects by interviews
• Because all human beings are limited to varying
degrees in their ability to recall information
• Some of the cases or controls who were exposed
will be erroneously classified as unexposed
• and some who were not exposed will be
erroneously classified as exposed
• leads to an underestimate of the true risk of the
disease associated with the exposure
6/26/2017 31
Recall Bias
• possible relationship of congenital malformations to
prenatal infections
• Interview mothers of children with congenital
malformations (cases) and mothers of children without
malformations (controls)
• Each mother is questioned about infections during the
pregnancy
• A mother who has had a child with a birth defect tries to
identify some unusual event that occurred during her
pregnancy
• She wants to know whether the abnormality was caused
• a mother of a child without a birth defect may not even
notice or may have forgotten entirely
• This type of bias is known as recall bias
6/26/2017 32
Matching
• the process of selecting the controls so that
they are similar to the cases in certain
characteristics, such as age, race, sex,
socioeconomic status, and occupation
• Matching may be of two types:
(1) group matching
(2) individual matching
6/26/2017 33
Group Matching
• Group matching (or frequency matching)
• selecting the controls with the same
characteristic
• If cases are married, controls will be also
married
6/26/2017 34
Individual Matching
• Individual matching (or matched pairs)
• a control is selected who is similar to the case
• E.g.
• if the first case enrolled in our study is a 45-year-
old white woman,
• we will seek a 45-year-old white female control
• the second case is a 24-year-old black man,
• we will select a control who is also a 24-year-old
black man
6/26/2017 35
Practical Problems with Matching
• to match according to too many characteristics,
• difficult or impossible to identify an appropriate
control
• E.g.
• If the case is a 48-year-old black woman who is
married, has four children, lives in zip code
21209, and works in a photo-processing plant,
• it may prove difficult or impossible to find a
control
6/26/2017 36
Conceptual Problems with Matching
• More important problem
• If we match the cases (breast cancer) and the controls (no
breast cancer) for marital status,
• we can no longer study whether or not marital status is a
risk factor for breast cancer
• Why not? Because in matching according to marital status
• We have artificially established an identical proportion in
cases and controls
• if 35% of the cases are married,
• we create a control group in which 35% are also married
6/26/2017 37
• Unplanned matching may inadvertently occur
in case-control studies
• E.g.
• if we use neighborhood controls--matching for
socioeconomic status as well as for cultural
and other characteristics of a neighborhood
• If we use bestfriend controls--share many
lifestyle characteristics
• Planned or an inadvertent manner--
Overmatching
6/26/2017 38
Use of Multiple Controls
(1) Controls of Same Type
(1) Controls of Different Types
6/26/2017 39
Control of the Same Type
• two controls or three controls for each case
• used to increase the power of the study
• 1 case to 4 controls
• Why use multiple controls for each case?
• there may be a limit to the number of potential
cases available for study
• the number of cases cannot be increased without
either extending the study in time to enroll more
cases or developing a collaborative multicentered
study
6/26/2017 40
Multiple Controls of Different Types
• exposure of the hospital controls- not represent the rate of
exposure- in a population of nondiseased persons
• the controls may be a highly selected-non-diseased
individuals and have a different exposure experience
• hospitalized patients smoke more than people living in the
community
• we do not know what the prevalence level of smoking in
hospitalized controls represents or how to interpret a
comparison of these rates with those of the cases
• To address this problem, we may choose to use an
additional control group, such as neighborhood controls
6/26/2017 41
6/26/2017 42
• Case-control studies are also valuable when
the disease being investigated is rare
• Possible to identify cases for study from
disease registries, hospital records, or other
sources
• cohort study for a rare disease, an extremely
large study population may be needed in
order to observe a sufficient number of
individuals to develop the disease
• cohort design may involve many years of
follow-up and logistical difficulty and expense
6/26/2017 43
6/26/2017 44
6/26/2017 45
6/26/2017 46
Case-Control Studies based in a Defined Cohort
6/26/2017 47
Two Types
• Nested Case Control Study
• Case Cohort Study
6/26/2017 48
Nested Case-Control Studies
• A nested case-control study is conducted
within a defined cohort in which exposure
data and population characteristics are
available to some extent, often from the time
of enrollment into the cohort
6/26/2017 49
• Both cases and controls are from a known,
defined population at risk of disease
• Exposure data are collected prior to the diagnosis
of the disease
• Information collected has not been influenced by
the knowledge of disease status (no
interviewer/information bias)
• Is less costly than a cohort study because fewer
subjects and fewer tests and/or specimens are
required
6/26/2017 50
• In a study to determine whether the
helicobecter pylori infection was associated
with the development of gastric cancer, 189
patients with gastric cancer and 189 cancer-
free individuals were identified from 130,000
people from a cohort followed since the 1960s
• Helicobacter pylori infection status was
determined using stored serum collected
during the 1960s
6/26/2017 51
Example
• Figure - A shows the starting point as a
defined cohort of individuals
• Some of them develop the disease in question
but most do not
• In this hypothetical example, the cohort is
observed over a 5-year period
• During this time, 5 cases develop—1 case
after 1 year, 1 after 2 years, 2 after 4 years,
and 1 after 5 years
6/26/2017 52
6/26/2017 53
• Figures - B–I show the time sequence in which
the cases develop after the start of observations
• At the time each case or cases develop, the same
number of controls is selected
• The solid arrows on the left side of the figure
denote the appearance of cases of the disease
• and the dotted arrows on the right side denote
the selection of controls who aredisease-free but
who are at risk of developing the disease
6/26/2017 54
• Figure - B shows case #1 developing after 1 year
and Figure - C shows control #1 being selected at
that time
• Figure - D shows case #2 developing after 2 years
and Figure - E shows control #2 being selected at
that time
• Figure – F shows cases #3 and #4 developing after
4 years and Figure - G shows controls #3 and #4
being selected at that time
• Finally, Figure - H shows the final case (#5)
developing after 5 years and
• Figure - I shows control #5 being selected at this
point
6/26/2017 55
6/26/2017 56
6/26/2017 57
6/26/2017 58
6/26/2017 59
6/26/2017 60
• Figure - I is also a summary of the design and the
final study populations used in the nested case-
control study
• At the end of 5 years, 5 cases have appeared and
at the times the cases appeared a total of 5
controls were selected for study
• In this way, the cases and controls are matched
on calendar time and length of follow-up
• Because a control is selected each time a case
develops
• a control who is selected early in the study could
later develop the disease and become a case in
the same study
6/26/2017 61
Advantages of Nested Case-Control Studies
• Possibility of recall bias is eliminated, since data
on exposure are obtained before disease
develops
• Exposure data are likely to represent the pre-
illness state since they are obtained years before
clinical illness is diagnosed
• Costs are reduced compared to those of a
prospective study, since laboratory tests need to
be done only on specimens from subjects who
are later chosen as cases or as controls
6/26/2017 62
Case-Cohort Studies
6/26/2017 63
• The second type of cohort-based case-control
study is the case-cohort design
• Cases develop at the same times that were
seen in the nested case-control design,
• but the controls are randomly chosen from
the defined cohort with which the study
began
• This subset of the full cohort is called the
subcohort
6/26/2017 64
• An advantage of this design is that because
controls are not individually matched to each
case, it is possible to study different diseases
(different sets of cases) in the same case-cohort
study using the same cohort for controls
• In this design, in contrast to the nested case-
control design, cases and controls are not
matched on calendar time and length of follow-
up;
• instead, exposure is characterized for the
subcohort
• This difference in study design needs to be taken
into account in analyzing the study results
6/26/2017 65
Ecologic Studies
• The first approach in determining whether an
association exists might be to conduct studies of
group characteristics, called ecologic studies
• the relationship between breast cancer incidence
and average dietary fat consumption in each
country
• The higher the average dietary fat consumption,
the higher breast cancer incidence
• conclude that dietary fat may be a causal factor
for breast cancer
6/26/2017 66
6/26/2017 67
• The problem is that we do not know whether
the individuals who developed breast cancer
actually had high dietary fat intake
• All we have are average values
• it is conceivable that those who developed
breast cancer ate very little dietary fat
• That does not reveal whether this might be
true
• individuals in each country are characterized
by the average figure
6/26/2017 68
• This problem is called the ecologic fallacy
• we may be ascribing to members of a group
that they in fact do not possess as individuals
• We only have data for groups
• we do not have exposure and outcome data
6/26/2017 69
Comparison of Cohort and Case-Control
Studies
• Table 13-1
• Page - 241
6/26/2017 70
6/26/2017 71
THANK YOU!!
6/26/2017 72

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Study designs
Study designsStudy designs
Study designs
 
Biases in epidemiology
Biases in epidemiologyBiases in epidemiology
Biases in epidemiology
 
Epidemiological Studies
Epidemiological StudiesEpidemiological Studies
Epidemiological Studies
 
Survival analysis & Kaplan Meire
Survival analysis & Kaplan MeireSurvival analysis & Kaplan Meire
Survival analysis & Kaplan Meire
 
Cohort ppt
Cohort pptCohort ppt
Cohort ppt
 
Case control study
Case control studyCase control study
Case control study
 
Bias and confounding
Bias and confoundingBias and confounding
Bias and confounding
 
Epidemiology Study Design
Epidemiology Study DesignEpidemiology Study Design
Epidemiology Study Design
 
Case control study
Case control studyCase control study
Case control study
 
Study designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studiesStudy designs, Epidemiological study design, Types of studies
Study designs, Epidemiological study design, Types of studies
 
Relative and Atribute Risk
Relative and Atribute RiskRelative and Atribute Risk
Relative and Atribute Risk
 
Ecological study
Ecological studyEcological study
Ecological study
 
Observational descriptive study: case report, case series & ecological study
Observational descriptive study: case report, case series & ecological studyObservational descriptive study: case report, case series & ecological study
Observational descriptive study: case report, case series & ecological study
 
Cross sectional study
Cross sectional studyCross sectional study
Cross sectional study
 
Screening for diseases
Screening for diseasesScreening for diseases
Screening for diseases
 
Study designs
Study designsStudy designs
Study designs
 
Survival analysis
Survival analysis  Survival analysis
Survival analysis
 
Cohort study
Cohort studyCohort study
Cohort study
 
5. cohort studies
5. cohort  studies5. cohort  studies
5. cohort studies
 
RSS 2012 Study designs
RSS 2012 Study designsRSS 2012 Study designs
RSS 2012 Study designs
 

Andere mochten auch

Effective clinical trial design
Effective clinical trial designEffective clinical trial design
Effective clinical trial designidkpharma
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory PracticesSwapnil Fernandes
 
Good laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticalsGood laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticalssrilakshmisadam
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial designSandhya Talla
 
Good Manufacturing Practices For Quality Control
Good Manufacturing Practices For Quality ControlGood Manufacturing Practices For Quality Control
Good Manufacturing Practices For Quality ControlDr Rajendra Patel
 
Good Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patilGood Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patilSwapnil Patil
 
good laboratory practices
good laboratory practicesgood laboratory practices
good laboratory practicesrasika walunj
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial designUrmila Aswar
 
Case control study – part 1
Case control study – part 1Case control study – part 1
Case control study – part 1Rizwan S A
 
Good Clinical Practices
Good Clinical PracticesGood Clinical Practices
Good Clinical PracticesKarun Kumar
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoringNaser Tadvi
 
Antibiotics requiring therapeutic drug monitoring(1)
Antibiotics requiring therapeutic drug monitoring(1)Antibiotics requiring therapeutic drug monitoring(1)
Antibiotics requiring therapeutic drug monitoring(1)Mahen Kothalawala
 
Good Laboratory Practice Documentation
Good Laboratory Practice DocumentationGood Laboratory Practice Documentation
Good Laboratory Practice DocumentationSunando Basu
 
Drug receptor interactions and types of receptor
Drug receptor interactions and types of receptorDrug receptor interactions and types of receptor
Drug receptor interactions and types of receptorDr. Siddhartha Dutta
 
Good Manufacturing Practice (GMP) 2day course
Good Manufacturing Practice (GMP) 2day course Good Manufacturing Practice (GMP) 2day course
Good Manufacturing Practice (GMP) 2day course Jo Havemann
 

Andere mochten auch (20)

Effective clinical trial design
Effective clinical trial designEffective clinical trial design
Effective clinical trial design
 
Good Laboratory Practices (http://www.ubio.in)
Good Laboratory Practices (http://www.ubio.in)Good Laboratory Practices (http://www.ubio.in)
Good Laboratory Practices (http://www.ubio.in)
 
Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory Practices
 
Good laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticalsGood laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticals
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial design
 
Good Manufacturing Practices For Quality Control
Good Manufacturing Practices For Quality ControlGood Manufacturing Practices For Quality Control
Good Manufacturing Practices For Quality Control
 
Good Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patilGood Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patil
 
good laboratory practices
good laboratory practicesgood laboratory practices
good laboratory practices
 
Animal Handling Program
Animal Handling ProgramAnimal Handling Program
Animal Handling Program
 
Clinical trial design
Clinical trial designClinical trial design
Clinical trial design
 
Case control study – part 1
Case control study – part 1Case control study – part 1
Case control study – part 1
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
Good Clinical Practices
Good Clinical PracticesGood Clinical Practices
Good Clinical Practices
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
Antibiotics requiring therapeutic drug monitoring(1)
Antibiotics requiring therapeutic drug monitoring(1)Antibiotics requiring therapeutic drug monitoring(1)
Antibiotics requiring therapeutic drug monitoring(1)
 
Good Laboratory Practice Documentation
Good Laboratory Practice DocumentationGood Laboratory Practice Documentation
Good Laboratory Practice Documentation
 
Drug receptor interactions and types of receptor
Drug receptor interactions and types of receptorDrug receptor interactions and types of receptor
Drug receptor interactions and types of receptor
 
Principle of good clinical practice
Principle of good clinical practicePrinciple of good clinical practice
Principle of good clinical practice
 
Good Manufacturing Practice (GMP) 2day course
Good Manufacturing Practice (GMP) 2day course Good Manufacturing Practice (GMP) 2day course
Good Manufacturing Practice (GMP) 2day course
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 

Ähnlich wie Case control & other study designs-i-dr.wah

Case control study
Case control studyCase control study
Case control studyNayanaM13
 
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
2010-Epidemiology (Dr. Sameem) basics and priciples.pptAmirRaziq1
 
Case Control Study Design
Case Control Study DesignCase Control Study Design
Case Control Study Designanmolayaz
 
MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...
MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...
MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...MedicReS
 
Case control studies and cohort studies
Case control studies and cohort studiesCase control studies and cohort studies
Case control studies and cohort studiesSaharshanSalam
 
Seminar case control study
Seminar case control studySeminar case control study
Seminar case control studyRadhika Maniyar
 
Case control study
Case control studyCase control study
Case control studyBPKIHS
 
COHORT STUDIES.pptx
COHORT STUDIES.pptxCOHORT STUDIES.pptx
COHORT STUDIES.pptxreshmasu
 
Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda
Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda
Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda umfrfouda
 
Fundamentals of study.pptx
Fundamentals of study.pptxFundamentals of study.pptx
Fundamentals of study.pptxbukolaabioye
 
4.1 case-control and cohort.pdf
4.1 case-control and cohort.pdf4.1 case-control and cohort.pdf
4.1 case-control and cohort.pdfmergawekwaya
 
Week 02, Stux f gfgzgzch nxfgnfxndy Designs.pptx
Week 02, Stux f gfgzgzch nxfgnfxndy Designs.pptxWeek 02, Stux f gfgzgzch nxfgnfxndy Designs.pptx
Week 02, Stux f gfgzgzch nxfgnfxndy Designs.pptxsaeedapkli
 
Screening for diseases sensitivity and specificity
Screening for diseases sensitivity and specificityScreening for diseases sensitivity and specificity
Screening for diseases sensitivity and specificityDrSumanB
 
Observational analytical and interventional studies
Observational analytical and interventional studiesObservational analytical and interventional studies
Observational analytical and interventional studiesAchyut Raj Pandey
 

Ähnlich wie Case control & other study designs-i-dr.wah (20)

Screening of disease
Screening of diseaseScreening of disease
Screening of disease
 
Case control study
Case control studyCase control study
Case control study
 
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
2010-Epidemiology (Dr. Sameem) basics and priciples.ppt
 
Case Control Study Design
Case Control Study DesignCase Control Study Design
Case Control Study Design
 
MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...
MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...
MedicReS Winter School 2017 Vienna - Advanced Clinical Practice in Oncology -...
 
Screening
ScreeningScreening
Screening
 
Case control studies and cohort studies
Case control studies and cohort studiesCase control studies and cohort studies
Case control studies and cohort studies
 
Seminar case control study
Seminar case control studySeminar case control study
Seminar case control study
 
STUDY DESIGN.pptx
STUDY   DESIGN.pptxSTUDY   DESIGN.pptx
STUDY DESIGN.pptx
 
Case_Control_Study.pptx
Case_Control_Study.pptxCase_Control_Study.pptx
Case_Control_Study.pptx
 
Case control study
Case control studyCase control study
Case control study
 
COHORT STUDIES.pptx
COHORT STUDIES.pptxCOHORT STUDIES.pptx
COHORT STUDIES.pptx
 
Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda
Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda
Fundamentals of clinical research and experimental design, Prof. Usama M.Fouda
 
Fundamentals of study.pptx
Fundamentals of study.pptxFundamentals of study.pptx
Fundamentals of study.pptx
 
4.1 case-control and cohort.pdf
4.1 case-control and cohort.pdf4.1 case-control and cohort.pdf
4.1 case-control and cohort.pdf
 
Week 02, Stux f gfgzgzch nxfgnfxndy Designs.pptx
Week 02, Stux f gfgzgzch nxfgnfxndy Designs.pptxWeek 02, Stux f gfgzgzch nxfgnfxndy Designs.pptx
Week 02, Stux f gfgzgzch nxfgnfxndy Designs.pptx
 
Etiology Research.pptx
Etiology Research.pptxEtiology Research.pptx
Etiology Research.pptx
 
Case control studies.ppt
Case control studies.pptCase control studies.ppt
Case control studies.ppt
 
Screening for diseases sensitivity and specificity
Screening for diseases sensitivity and specificityScreening for diseases sensitivity and specificity
Screening for diseases sensitivity and specificity
 
Observational analytical and interventional studies
Observational analytical and interventional studiesObservational analytical and interventional studies
Observational analytical and interventional studies
 

Mehr von Mmedsc Hahm

Solid waste-management-2858710
Solid waste-management-2858710Solid waste-management-2858710
Solid waste-management-2858710Mmedsc Hahm
 
Situation analysis
Situation analysisSituation analysis
Situation analysisMmedsc Hahm
 
Quantification of medicines need
Quantification of medicines needQuantification of medicines need
Quantification of medicines needMmedsc Hahm
 
Quality in hospital
Quality in hospitalQuality in hospital
Quality in hospitalMmedsc Hahm
 
Patient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt wai
Patient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt waiPatient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt wai
Patient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt waiMmedsc Hahm
 
Introduction to hahm 2017
Introduction to hahm 2017Introduction to hahm 2017
Introduction to hahm 2017Mmedsc Hahm
 
Hss lecture 2016 jan
Hss lecture 2016 janHss lecture 2016 jan
Hss lecture 2016 janMmedsc Hahm
 
Hospital management17
Hospital management17Hospital management17
Hospital management17Mmedsc Hahm
 
Health planning approaches hahm 17
Health planning approaches hahm 17Health planning approaches hahm 17
Health planning approaches hahm 17Mmedsc Hahm
 
Directing and leading 2017
Directing and leading 2017Directing and leading 2017
Directing and leading 2017Mmedsc Hahm
 
Access to medicines p pt 17 10-2015
Access to medicines p pt 17 10-2015Access to medicines p pt 17 10-2015
Access to medicines p pt 17 10-2015Mmedsc Hahm
 
The dynamics of disease transmission
The dynamics of disease transmissionThe dynamics of disease transmission
The dynamics of disease transmissionMmedsc Hahm
 
Study designs dr.wah
Study designs dr.wahStudy designs dr.wah
Study designs dr.wahMmedsc Hahm
 
Standardization dr.wah
Standardization dr.wahStandardization dr.wah
Standardization dr.wahMmedsc Hahm
 

Mehr von Mmedsc Hahm (20)

Solid waste-management-2858710
Solid waste-management-2858710Solid waste-management-2858710
Solid waste-management-2858710
 
Situation analysis
Situation analysisSituation analysis
Situation analysis
 
Quantification of medicines need
Quantification of medicines needQuantification of medicines need
Quantification of medicines need
 
Quality in hospital
Quality in hospitalQuality in hospital
Quality in hospital
 
Patient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt wai
Patient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt waiPatient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt wai
Patient satisfaction & quality in health care (16.3.2016) dr.nyunt nyunt wai
 
Organising
OrganisingOrganising
Organising
 
Nscbl slide
Nscbl slideNscbl slide
Nscbl slide
 
Introduction to hahm 2017
Introduction to hahm 2017Introduction to hahm 2017
Introduction to hahm 2017
 
Hss lecture 2016 jan
Hss lecture 2016 janHss lecture 2016 jan
Hss lecture 2016 jan
 
Hospital management17
Hospital management17Hospital management17
Hospital management17
 
Hopital stat
Hopital statHopital stat
Hopital stat
 
Health planning approaches hahm 17
Health planning approaches hahm 17Health planning approaches hahm 17
Health planning approaches hahm 17
 
Ephs and nhp
Ephs and nhpEphs and nhp
Ephs and nhp
 
Directing and leading 2017
Directing and leading 2017Directing and leading 2017
Directing and leading 2017
 
Concepts of em
Concepts of emConcepts of em
Concepts of em
 
Access to medicines p pt 17 10-2015
Access to medicines p pt 17 10-2015Access to medicines p pt 17 10-2015
Access to medicines p pt 17 10-2015
 
The dynamics of disease transmission
The dynamics of disease transmissionThe dynamics of disease transmission
The dynamics of disease transmission
 
Study designs dr.wah
Study designs dr.wahStudy designs dr.wah
Study designs dr.wah
 
Standardization dr.wah
Standardization dr.wahStandardization dr.wah
Standardization dr.wah
 
Sdg
SdgSdg
Sdg
 

Kürzlich hochgeladen

Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅gragmanisha42
 
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service available
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service availableCall Girl Raipur 📲 9999965857 whatsapp live cam sex service available
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service availablegragmanisha42
 
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near MeRussian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Memriyagarg453
 
(Sonam Bajaj) Call Girl in Jaipur- 09257276172 Escorts Service 50% Off with C...
(Sonam Bajaj) Call Girl in Jaipur- 09257276172 Escorts Service 50% Off with C...(Sonam Bajaj) Call Girl in Jaipur- 09257276172 Escorts Service 50% Off with C...
(Sonam Bajaj) Call Girl in Jaipur- 09257276172 Escorts Service 50% Off with C...indiancallgirl4rent
 
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetnagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girl Gorakhpur * 8250192130 Service starts from just ₹9999 ✅
Call Girl Gorakhpur * 8250192130 Service starts from just ₹9999 ✅Call Girl Gorakhpur * 8250192130 Service starts from just ₹9999 ✅
Call Girl Gorakhpur * 8250192130 Service starts from just ₹9999 ✅gragmanisha42
 
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...Sheetaleventcompany
 
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...Gfnyt.com
 
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetOzhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In RaipurCall Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipurgragmanisha42
 
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetbhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetCall Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meetpriyashah722354
 
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetErnakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Chandigarh
 
Jalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Jalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetJalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Jalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...Sheetaleventcompany
 
VIP Call Girl Sector 10 Noida Call Me: 9711199171
VIP Call Girl Sector 10 Noida Call Me: 9711199171VIP Call Girl Sector 10 Noida Call Me: 9711199171
VIP Call Girl Sector 10 Noida Call Me: 9711199171Call Girls Service Gurgaon
 
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetHubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetCall Girls Service
 
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In FaridabadCall Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabadgragmanisha42
 

Kürzlich hochgeladen (20)

Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
Russian Call Girls Kota * 8250192130 Service starts from just ₹9999 ✅
 
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service available
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service availableCall Girl Raipur 📲 9999965857 whatsapp live cam sex service available
Call Girl Raipur 📲 9999965857 whatsapp live cam sex service available
 
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near MeRussian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
Russian Call Girls in Noida Pallavi 9711199171 High Class Call Girl Near Me
 
(Sonam Bajaj) Call Girl in Jaipur- 09257276172 Escorts Service 50% Off with C...
(Sonam Bajaj) Call Girl in Jaipur- 09257276172 Escorts Service 50% Off with C...(Sonam Bajaj) Call Girl in Jaipur- 09257276172 Escorts Service 50% Off with C...
(Sonam Bajaj) Call Girl in Jaipur- 09257276172 Escorts Service 50% Off with C...
 
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetnagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
nagpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Thane Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girl Gorakhpur * 8250192130 Service starts from just ₹9999 ✅
Call Girl Gorakhpur * 8250192130 Service starts from just ₹9999 ✅Call Girl Gorakhpur * 8250192130 Service starts from just ₹9999 ✅
Call Girl Gorakhpur * 8250192130 Service starts from just ₹9999 ✅
 
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
Call Girl Amritsar ❤️♀️@ 8725944379 Amritsar Call Girls Near Me ❤️♀️@ Sexy Ca...
 
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR   Call G...
❤️♀️@ Jaipur Call Girls ❤️♀️@ Meghna Jaipur Call Girls Number CRTHNR Call G...
 
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetOzhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ozhukarai Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In RaipurCall Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
Call Girl Raipur 📲 9999965857 ヅ10k NiGhT Call Girls In Raipur
 
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetbhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real MeetCall Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh 👙 7001035870 👙 Genuine WhatsApp Number for Real Meet
 
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetErnakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Ernakulam Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Jalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Jalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetJalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Jalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
Call Girl In Zirakpur ❤️♀️@ 9988299661 Zirakpur Call Girls Near Me ❤️♀️@ Sexy...
 
VIP Call Girl Sector 10 Noida Call Me: 9711199171
VIP Call Girl Sector 10 Noida Call Me: 9711199171VIP Call Girl Sector 10 Noida Call Me: 9711199171
VIP Call Girl Sector 10 Noida Call Me: 9711199171
 
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetHubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Hubli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In FaridabadCall Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
Call Girls Service Faridabad 📲 9999965857 ヅ10k NiGhT Call Girls In Faridabad
 

Case control & other study designs-i-dr.wah

  • 1. Case-Control & Other Study Designs Dr. Win Aye Hlaing Lecturer Department of Epidemiology University of Public Health, Yangon 6/26/2017 1
  • 2. • In the early 1940s, Alton Ochsner, a surgeon • observed that patients with lung cancer gave a history of cigarette smoking • relationship is accepted and well recognized today • it was relatively new and controversial at the time • He hypothesized that cigarette smoking was linked to lung cancer 6/26/2017 2
  • 3. • In 1940s, Sir Norman Gregg, an Australian ophthalmologist • observed a number of infants and young children who presented with an unusual form of cataract • noted that these children had been in utero during the time of a rubella (German measles) outbreak • Association between prenatal rubella exposure and development of the unusual cataracts • at that time there was no knowledge that a virus could be teratogenic • he proposed his hypothesis solely on the basis of observational data 6/26/2017 3
  • 4. • 90% of these infants had been in utero during the rubella outbreak • concluding that rubella was associated with the cataracts? • Clearly, the answer is no • difficult to interpret without data for a comparison group of children without cataracts • Study both mothers of children with the cataracts and without cataracts • They had been pregnant during the outbreak of rubella • exposure history-no different for mothers of children with cataracts than for mothers of controls • the prevalence of rubella exposure was greater in children with cataracts than in a group of children without cataracts 6/26/2017 4
  • 5. • To determine the significance of such observations • a comparison or control group is needed • Without such a comparison, only constitute a case series 6/26/2017 5
  • 7. DESIGN OF A CASE-CONTROL STUDY • A group of people with that disease (cases) • A group of people without that disease(controls) • Cases were exposed and were not • Controls were exposed and were not • case-control study---if there is an association of an exposure with a disease, • the prevalence of history of exposure---higher in persons who have the disease (cases) than in those who do not have the disease (controls) 6/26/2017 7
  • 8. 6/26/2017 8 Case [Disease (+)] Control [Disease (-)] Exposure (+) a b Exposure (-) c d a+c b+d a/a+c b/b+d
  • 9. • by selecting cases (with the disease) and controls (without the disease) • and then measure past exposure by interview and by review of medical or employee records or of results of chemical or biologic assays of blood, urine, or tissues 6/26/2017 9
  • 10. • If exposure is associated with disease, a/a + c ˃ b/b + d • proportion of the cases who were exposed is greater than proportion of the controls who were exposed 6/26/2017 10
  • 12. • data from a case-control study, • We cannot estimate the prevalence of the disease • E.g. we had 200 cases and 400 controls, but this does not imply that the prevalence is 33% or 200/200 + 400 6/26/2017 12
  • 13. • the investigator could have selected • 200 cases and 200 controls (1 control per case), or • 200 cases and 800 controls (4 controls per case) • Because the proportion of the entire study population that consists of cases is determined by the ratio of controls per case, and this proportion is determined by the investigator, it clearly does not reflect the true prevalence 6/26/2017 13
  • 14. • erroneous impression that – cohort studies go forward in time and – case-control studies go backward in time • Such a distinction is not correct • retrospective has been used for case-control studies • But retrospective cohort study also uses data obtained in the past • Thus, calendar time is not the characteristic that distinguishes a case-control from a cohort study 6/26/2017 14
  • 15. • Why the unusual number of controls? • The investigation planned for two controls per case (400 controls), and that some of the controls did not participate 6/26/2017 15
  • 16. Potential Biases in Case-Control Studies • Selection Bias – Selection of case – Selection of control • Information Bias – Limitations in recall – Recall bias 6/26/2017 16
  • 17. Selection Bias – Selection of Case • cases can be selected from a variety of sources, including hospital patients, patients in physicians’ practices, or clinic patients • Several problems---selected from a single hospital • results may not be generalizable to all patients with the disease • cases are drawn from a tertiary care facility, which selectively admits severely ill patients--- risk factors only in persons with severe forms of the disease 6/26/2017 17
  • 18. Using Incident or Prevalent Cases • if we use prevalent cases(already been diagnosed) : – a larger number of cases is often available for study and – Most people with disease die soon after diagnosis – Underrepresented in a study – Highly non-representative group of cases 6/26/2017 18
  • 19. • If we use incident cases: – The problem is - wait for new cases to be diagnosed – But can exclude that any patients who may have died before the diagnosis was made 6/26/2017 19
  • 20. Selection of Controls • In 1929, Johns Hopkins University • test the hypothesis that tuberculosis protected against cancer • From total 7,500 consecutive autopsies • Selected 816 cases of cancer and control group of 816 6/26/2017 20
  • 21. 6/26/2017 21 Case [Cancer (+)] Control [Cancer(-)] TB (+) 54 133 TB (-) 762 683 816 816 6.6% 16.3%
  • 22. • Of the 816 autopsies of patients with cancer • 54 had tuberculosis (6.6%) • whereas of the 816 controls with no cancer • 133 had tuberculosis (16.3%) • the prevalence of tuberculosis was higher in the control group than in the case group • concluded that tuberculosis had an antagonistic or protective effect against cancer 6/26/2017 22
  • 23. • At the time of the study, tuberculosis was one of the major reasons for hospitalization at Johns Hopkins Hospital • Inadvertently done in choosing the cancer-free control group was diagnosed with and hospitalized for tuberculosis • selected the controls, they came from a pool that was heavily weighted with tuberculosis patients, which did not represent the general population • Clearly, this conclusion was not justified on the basis of these data 6/26/2017 23
  • 24. • A fundamental conceptual issue relating to selection of controls is: • the controls should be similar to the cases in all respects other than having the disease or • they should be representative of all persons without the disease in the population from which the cases are selected 6/26/2017 24
  • 25. • Controls may be selected • from non-hospitalized persons living in the community or • from hospitalized patients admitted for diseases other than that for which the cases were admitted 6/26/2017 25
  • 27. Use of Hospitalized Patients as Controls • more economical • ill-defined reference population that generally cannot be characterized • a conceptual attractiveness to comparing hospitalized cases to hospitalized controls from the same institution who come from the same reference population 6/26/2017 27
  • 28. Use of Non-Hospitalized People as Controls • Other sources include school rosters, selective service lists, and insurance company lists • neighborhood in which the case lives--- neighborhood controls • identify the home of a case as a starting point • and from there walk past a specified number of houses in a specified direction and seek the first household that contains an eligible control • Because of increasing problems of security in US, many people will no longer open their doors to interviewers • in developing countries, the door-to door approach to obtaining controls may be ideal 6/26/2017 28
  • 29. • Alternate method for selecting such controls is to use random digit dialing • a case’s seven-digit telephone number, • the first three digits are the constant, • the terminal four digits of the phone number are randomly selected 6/26/2017 29
  • 30. • Another approach to control selection is to use a best friend control • A case is asked for the name of a best friend who participate in the study • there are also disadvantages: • A control is similar to the case in age and in many other demographic and social characteristics • A resulting problem may be that the controls may be too similar to the cases in regard to many variables, including the variables that are being investigated in the study • it may be useful to select a spouse or sibling control • a sibling may provide some control over genetic things 6/26/2017 30
  • 31. Information Bias – Limitations in Recall • collecting data from subjects by interviews • Because all human beings are limited to varying degrees in their ability to recall information • Some of the cases or controls who were exposed will be erroneously classified as unexposed • and some who were not exposed will be erroneously classified as exposed • leads to an underestimate of the true risk of the disease associated with the exposure 6/26/2017 31
  • 32. Recall Bias • possible relationship of congenital malformations to prenatal infections • Interview mothers of children with congenital malformations (cases) and mothers of children without malformations (controls) • Each mother is questioned about infections during the pregnancy • A mother who has had a child with a birth defect tries to identify some unusual event that occurred during her pregnancy • She wants to know whether the abnormality was caused • a mother of a child without a birth defect may not even notice or may have forgotten entirely • This type of bias is known as recall bias 6/26/2017 32
  • 33. Matching • the process of selecting the controls so that they are similar to the cases in certain characteristics, such as age, race, sex, socioeconomic status, and occupation • Matching may be of two types: (1) group matching (2) individual matching 6/26/2017 33
  • 34. Group Matching • Group matching (or frequency matching) • selecting the controls with the same characteristic • If cases are married, controls will be also married 6/26/2017 34
  • 35. Individual Matching • Individual matching (or matched pairs) • a control is selected who is similar to the case • E.g. • if the first case enrolled in our study is a 45-year- old white woman, • we will seek a 45-year-old white female control • the second case is a 24-year-old black man, • we will select a control who is also a 24-year-old black man 6/26/2017 35
  • 36. Practical Problems with Matching • to match according to too many characteristics, • difficult or impossible to identify an appropriate control • E.g. • If the case is a 48-year-old black woman who is married, has four children, lives in zip code 21209, and works in a photo-processing plant, • it may prove difficult or impossible to find a control 6/26/2017 36
  • 37. Conceptual Problems with Matching • More important problem • If we match the cases (breast cancer) and the controls (no breast cancer) for marital status, • we can no longer study whether or not marital status is a risk factor for breast cancer • Why not? Because in matching according to marital status • We have artificially established an identical proportion in cases and controls • if 35% of the cases are married, • we create a control group in which 35% are also married 6/26/2017 37
  • 38. • Unplanned matching may inadvertently occur in case-control studies • E.g. • if we use neighborhood controls--matching for socioeconomic status as well as for cultural and other characteristics of a neighborhood • If we use bestfriend controls--share many lifestyle characteristics • Planned or an inadvertent manner-- Overmatching 6/26/2017 38
  • 39. Use of Multiple Controls (1) Controls of Same Type (1) Controls of Different Types 6/26/2017 39
  • 40. Control of the Same Type • two controls or three controls for each case • used to increase the power of the study • 1 case to 4 controls • Why use multiple controls for each case? • there may be a limit to the number of potential cases available for study • the number of cases cannot be increased without either extending the study in time to enroll more cases or developing a collaborative multicentered study 6/26/2017 40
  • 41. Multiple Controls of Different Types • exposure of the hospital controls- not represent the rate of exposure- in a population of nondiseased persons • the controls may be a highly selected-non-diseased individuals and have a different exposure experience • hospitalized patients smoke more than people living in the community • we do not know what the prevalence level of smoking in hospitalized controls represents or how to interpret a comparison of these rates with those of the cases • To address this problem, we may choose to use an additional control group, such as neighborhood controls 6/26/2017 41
  • 43. • Case-control studies are also valuable when the disease being investigated is rare • Possible to identify cases for study from disease registries, hospital records, or other sources • cohort study for a rare disease, an extremely large study population may be needed in order to observe a sufficient number of individuals to develop the disease • cohort design may involve many years of follow-up and logistical difficulty and expense 6/26/2017 43
  • 47. Case-Control Studies based in a Defined Cohort 6/26/2017 47
  • 48. Two Types • Nested Case Control Study • Case Cohort Study 6/26/2017 48
  • 49. Nested Case-Control Studies • A nested case-control study is conducted within a defined cohort in which exposure data and population characteristics are available to some extent, often from the time of enrollment into the cohort 6/26/2017 49
  • 50. • Both cases and controls are from a known, defined population at risk of disease • Exposure data are collected prior to the diagnosis of the disease • Information collected has not been influenced by the knowledge of disease status (no interviewer/information bias) • Is less costly than a cohort study because fewer subjects and fewer tests and/or specimens are required 6/26/2017 50
  • 51. • In a study to determine whether the helicobecter pylori infection was associated with the development of gastric cancer, 189 patients with gastric cancer and 189 cancer- free individuals were identified from 130,000 people from a cohort followed since the 1960s • Helicobacter pylori infection status was determined using stored serum collected during the 1960s 6/26/2017 51
  • 52. Example • Figure - A shows the starting point as a defined cohort of individuals • Some of them develop the disease in question but most do not • In this hypothetical example, the cohort is observed over a 5-year period • During this time, 5 cases develop—1 case after 1 year, 1 after 2 years, 2 after 4 years, and 1 after 5 years 6/26/2017 52
  • 54. • Figures - B–I show the time sequence in which the cases develop after the start of observations • At the time each case or cases develop, the same number of controls is selected • The solid arrows on the left side of the figure denote the appearance of cases of the disease • and the dotted arrows on the right side denote the selection of controls who aredisease-free but who are at risk of developing the disease 6/26/2017 54
  • 55. • Figure - B shows case #1 developing after 1 year and Figure - C shows control #1 being selected at that time • Figure - D shows case #2 developing after 2 years and Figure - E shows control #2 being selected at that time • Figure – F shows cases #3 and #4 developing after 4 years and Figure - G shows controls #3 and #4 being selected at that time • Finally, Figure - H shows the final case (#5) developing after 5 years and • Figure - I shows control #5 being selected at this point 6/26/2017 55
  • 61. • Figure - I is also a summary of the design and the final study populations used in the nested case- control study • At the end of 5 years, 5 cases have appeared and at the times the cases appeared a total of 5 controls were selected for study • In this way, the cases and controls are matched on calendar time and length of follow-up • Because a control is selected each time a case develops • a control who is selected early in the study could later develop the disease and become a case in the same study 6/26/2017 61
  • 62. Advantages of Nested Case-Control Studies • Possibility of recall bias is eliminated, since data on exposure are obtained before disease develops • Exposure data are likely to represent the pre- illness state since they are obtained years before clinical illness is diagnosed • Costs are reduced compared to those of a prospective study, since laboratory tests need to be done only on specimens from subjects who are later chosen as cases or as controls 6/26/2017 62
  • 64. • The second type of cohort-based case-control study is the case-cohort design • Cases develop at the same times that were seen in the nested case-control design, • but the controls are randomly chosen from the defined cohort with which the study began • This subset of the full cohort is called the subcohort 6/26/2017 64
  • 65. • An advantage of this design is that because controls are not individually matched to each case, it is possible to study different diseases (different sets of cases) in the same case-cohort study using the same cohort for controls • In this design, in contrast to the nested case- control design, cases and controls are not matched on calendar time and length of follow- up; • instead, exposure is characterized for the subcohort • This difference in study design needs to be taken into account in analyzing the study results 6/26/2017 65
  • 66. Ecologic Studies • The first approach in determining whether an association exists might be to conduct studies of group characteristics, called ecologic studies • the relationship between breast cancer incidence and average dietary fat consumption in each country • The higher the average dietary fat consumption, the higher breast cancer incidence • conclude that dietary fat may be a causal factor for breast cancer 6/26/2017 66
  • 68. • The problem is that we do not know whether the individuals who developed breast cancer actually had high dietary fat intake • All we have are average values • it is conceivable that those who developed breast cancer ate very little dietary fat • That does not reveal whether this might be true • individuals in each country are characterized by the average figure 6/26/2017 68
  • 69. • This problem is called the ecologic fallacy • we may be ascribing to members of a group that they in fact do not possess as individuals • We only have data for groups • we do not have exposure and outcome data 6/26/2017 69
  • 70. Comparison of Cohort and Case-Control Studies • Table 13-1 • Page - 241 6/26/2017 70